Insights & Analysis

Industry insights that are curated and delivered to inform your dealmaking strategies. We select the most relevant information, providing a consistent, convenient source for exclusive intelligence and analysis.

All News Activism M&A Podcasts Private Cos. Private Equity Restructuring Scoops & Exclusives SPACs

Page 41

M&A

DOJ Weighs Stricter Bank Merger Guidelines

By David Hatch
|
Published: December 20th, 2021
The department's request for input on the rigor and scope of its 26-year-old protocols follows the arrival of Jonathan Kanter as chief of the antitrust division.
Activism

Share Lending Under Fire

By Ronald Orol
|
Published: December 17th, 2021
A regulatory proposal requiring big index fund managers and other institutional investors to disclose share lending programs could upend short-selling activism and drive an uptick in ESG voting.
M&A

Bouchard Looks Back at Chancery, Ahead at Paul Weiss

By David Marcus
|
Published: December 17th, 2021
In Part Two of our extended interview, former Delaware Chancellor Andre Bouchard discusses the expansion of the Court of Chancery, changes in the litigation the court is seeing and his practice at Paul Weiss.
Activism

Drinks With The Deal: Eduardo Gallardo of Gibson Dunn

By David Marcus
|
Published: December 16th, 2021
Eduardo Gallardo, co-chair of M&A and chair of the activist defense group at Gibson Dunn, discusses the universal proxy, the Williams case and more on this week's Drinks With The Deal podcast.
M&A

Neogen, 3M Food Safety to Combine

By Nikitha Sattiraju
|
Published: December 14th, 2021
St. Paul, Minn.-based 3M agrees to separate its food safety business and combine it with Neogen in a deal that values the combined company at $9.3 billion.
M&A

SPX Flow Agrees to Lone Star Take-Private

By Tom Terrarosa
|
Published: December 13th, 2021
Analysts favor guaranteed cash in a roughly $3.6 billion deal over the execution risk associated with continuing as a standalone company amid a recent supply chain crunch.
Podcasts

Drinks With The Deal: Gregory Varallo of Bernstein Litowitz

By David Marcus
|
Published: December 9th, 2021
The Delaware partner discusses the switch from representing companies to working with shareholders, Andy Bouchard's achievements as chancellor, his love of hunting, poker and the American University of Rome and more in this week's episode.
Activism

Drinks With The Deal: Willkie's Tariq Mundiya

By David Marcus
|
Published: December 2nd, 2021
Willkie head of litigation Tariq Mundiya discusses the Williams poison pill case from earlier this year as well as the CytoDyn decision and the evolution of Delaware's Caremark doctrine in this week's Drinks With The Deal podcast.
 Company
Solutions
Contact The Deal
Tel:
1-888-667-3325
International:
+1-212-224-3069
Email:
[email protected]
© 2024 The Deal.

Part of the Delinian Group. Terms of Use, Commercial Terms & Conditions, Privacy Policy, Accessibility, Modern Slavery Act